Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2024

Dec 3, 2024

30071_dirs_2024-12-02_d616f76e-2cf8-447c-ba6f-ef6fb679e139.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-11-29

Reporting Person: Rider Michael J (Global General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-29 ResMed Common Stock G 173 Disposed 9187 Direct
2024-12-02 ResMed Common Stock S 74 $248.91 Disposed 9113 Direct

Footnotes

F1: Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Rider has no beneficial interest, control or dispositive power over the gifted shares.

F2: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024.